SkinXCare
Integral cell-biology platform for the development of the first effective treatment of radiodermatitis.
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0SkinXCare project word cloud
Explore the words cloud of the SkinXCare project. It provides you a very rough idea of what is the project "SkinXCare" about.
Project "SkinXCare" data sheet
The following table provides information about the project.
| Coordinator |
INNOVATIVEHEALTH GROUP SL
Organization address contact info |
| Coordinator Country | Spain [ES] |
| Project website | http://www.innohealthgroup.com/simhealth/skinxcare |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.3.1.3. (Treating and managing disease) |
| Code Call | H2020-SMEINST-1-2016-2017 |
| Funding Scheme | SME-1 |
| Starting year | 2016 |
| Duration (year-month-day) | from 2016-12-01 to 2017-03-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | INNOVATIVEHEALTH GROUP SL | ES (MADRID) | coordinator | 50˙000.00 |
Map
Project objective
InnoHealth Group is a private company born with the mission of offering novel dermatological formulations, with a major focus on the rational development (scientific-based approach) of new and more effective therapeutic solutions to dermatological diseases. Our vision is to become a leading player of the therapeutic dermatology and skin care markets segments, something that will be enabled thanks to our patented cell biology platform for the development of novel products. Our platform is the only one in the market that integrates novel bioinformatic tools based on cellular proteomic/kinome data (SkinSim and INCOS) and in vitro assays (SimDerma) for the rational design and development of new dermatological formulations. The combination of these tools in the platform allows identifying the molecular/celular targets involved in skin diseases and the combinations of active ingredients/compounds with the highest synergistic activity in these targets for disease treatment. This makes our platform a key enabling technology for the development of new dermatological products, especially in treatment of skin diseases without a known efficient therapeutic solution because of the complexity in the cellular and biochemical damages underlying such diseases. In the SkinXCare project we seek demonstrating the potential of our platform by its use in the development of the first effective treatment of radiodermatitis, a severe skin condition that affects cancer patients undergoing radiotherapy and still remains an unmet clinical condition. Thanks to the uniqueness of the solution proposed in the SkinXCare project, we seek becoming a leading player of therapeutic dermatology market. This market segment was valued at €24.5 billion on 2015 and is predicted to grow at a CAGR of 6.7% until 2025, key figures that further sustain the SkinXCare business opportunity.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SKINXCARE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "SKINXCARE" are provided by the European Opendata Portal: CORDIS opendata.